ArticlePathogens (Basel, Switzerland)2025
Stigma and Inequity in Tuberculosis Transmission and Control in the Philippines.
Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis remains endemic in the Philippines despite decades of biomedical progress under the WHO End TB Strategy. This persistence reflects not a failure of medicine, but of systems that treat tuberculosis as a biomedical issue rather than a social one. While public health programs recognize community factors, stigma is still framed as a problem of awareness rather than a structural outcome of health institutions. Practices of isolation, surveillance, and labeling have normalized fear and exclusion, shaping how communities perceive and respond to the disease. By pathologizing patients rather than confronting inequities, institutions perpetuate the very stigma that hinders diagnosis and treatment. To end tuberculosis, national frameworks, especially in low- and middle-income settings, must become stigma-responsive by embedding social trust, accountability, and equity as measurable goals alongside cure rates. Only then can the End TB Strategy's promise of universality and dignity be realized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.